Caterina Patti

<i>BRAF</i> Mutations in Hairy-Cell Leukemia

Enrico Tiacci, Gianluca Schiavoni, Antony B. Holmes et al. · New England Journal of Medicine · 2011 · 1K citations · Full text

Medicine, Genetics, Oncology +17

Early Interim 2-[ ¹⁸ F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study

Andrea Gallamini, Martin Hutchings, Luigi Rigacci et al. · Journal of Clinical Oncology · 2007 · 836 citations

Medicine, Oncology, Radiology +17

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

Anas Younes, Laurie H. Sehn, Peter Johnson et al. · Journal of Clinical Oncology · 2019 · 616 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial

Andrea Gallamini, Francesco Zaja, Caterina Patti et al. · Blood · 2007 · 308 citations · Full text

Medicine, Oncology, Chemotherapy +9

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Marco Ladetto, Federica De Marco, Fabio Benedetti et al. · Blood · 2008 · 253 citations · Full text

Medicine, Immunology, Oncology +11